logo
logo

Latest Financial Updates

Read latest financial news update from our blog

Charles Schwab Is A Buy At This Price (NYSE:SCHW)
Charles Schwab Is A Buy At This Price (NYSE:SCHW)

jetcityimage Introduction One company that I have been buying this year is Charles Schwa...

Admin | Finance | 1 month ago

read more
Happy Thanksgiving! 2023 YTD Winners
Happy Thanksgiving! 2023 YTD Winners

Pavel Muravev The average Russell 3,000 (a combination of the large-cap Russell 1,000 and...

Admin | Finance | 1 month ago

read more
5 myths and facts about travel insurance that everyone needs to know
5 myths and facts about travel insurance that everyone needs to know

Travel insurance is like a safety net, offering invaluable peace of mind when exploring th...

Admin | Finance | 1 month ago

read more
VICI Properties: A Good Bet For Higher For Longer (Rating Upgrade) (NYSE:VICI)
VICI Properties: A Good Bet For Higher For Longer (Rating Upgrade) (NYSE:VICI)

Nature, food, landscape, travel Dear readers, VICI Properties (NYSE:VICI) is a specializ...

Admin | Finance | 1 month ago

read more
Ukrainian students were told to go to a Crimean 'camp' for school only to be held captive in Russia, The Washington Post reports
Ukrainian students were told to go to a Crimean 'camp' for school only to be held captive in Russia, The Washington Post reports

Russia has been accused of forcibly removing thousands of Ukrainian children from their ho...

Admin | Finance | 1 month ago

read more
The Alfond Inn At Rollins Is A Hotel Designed For Art & Philanthropy
The Alfond Inn At Rollins Is A Hotel Designed For Art & Philanthropy

The new pool and terrace at The Alfond Inn at Rollins JOHN MCKINNON It’s not a stretch to...

Admin | Finance | 1 month ago

read more
Shahbaz Ahmed traded to SRH from RCB
Shahbaz Ahmed traded to SRH from RCB

Left-arm spinner Shahbaz Ahmed has been traded to Sunrisers Hyderabad from Royal Challenge...

Admin | Finance | 1 month ago

read more
A Biotech Slump Is Emptying Labs And Threatening Research On New Drugs
A Biotech Slump Is Emptying Labs And Threatening Research On New Drugs

Sangamo will finish a current Fabry trial as planned and is seeking funding or a partner f...

Admin | Finance | 1 month ago

read more

Join Our Newsletter

join our newsletter to receive update from us